Join Growin Stock Community!

Novanta inc.NOVT.US Overview

US StockTechnology
(No presentation for NOVT)
My Watchlist

Ticker

Value

empty

There is no following symbol in this watchlist.

NOVT AI Insights

NOVT Overall Performance

NOVT AI Analysis & Strategy

AI Strategy

Browsing restrictions can be lifted for a fee.

NOVT Recent Performance

-1.93%

Novanta inc.

-2.59%

Avg of Sector

-2.16%

S&P500

NOVT PowerScanner

Introduction >>

Power Squeeze

Surfing Trend

1 Day

1 Week

1 Month

NOVT Key Information

NOVT Financial Forecast

chart

Browsing restrictions can be lifted for a fee.

QuarterlyEPS ForecastQoQMaxMin
2026Q1
2026Q2
2026Q3
2026Q4
2027Q1

NOVT Profile

Novanta Inc., together with its subsidiaries, designs, manufactures, markets, and sells photonics, vision, and precision motion components and sub-systems to original equipment manufacturers in the medical and industrial markets worldwide. The company's Photonics segment offers photonics-based solutions, including laser scanning and beam delivery, CO2 laser, solid state laser, ultrafast laser, and optical light engine products serving photonics-based applications for industrial processing, metrology, medical and life science imaging, DNA sequencing, and medical laser procedures. It's Vision segment provides a range of medical grade technologies, including medical insufflators, pumps, and related disposables; visualization solutions; wireless technologies, video recorders, and video integration technologies for operating room integrations; optical data collection and machine vision technologies; radio frequency identification technologies; thermal chart recorders; spectrometry technologies; and embedded touch screen solutions. In addition, its Precision Motion segment offers optical and inductive encoders, precision motors, servo drives and motion control solutions, integrated stepper motors, intelligent robotic end-of-arm technology solutions, air bearings, and air bearing spindles. The company sells its products through its direct sales force, resellers, distributors, and system integrators under the Cambridge Technology, Synrad, Laser Quantum, ARGES, WOM, NDS, NDSsi, Med X Change, Reach Technology, JADAK, ThingMagic, Photo Research, Celera Motion, MicroE, Zettlex, Applimotion, Ingenia, and Westwind brands. The company was formerly known as GSI Group, Inc. and changed its name to Novanta Inc. in May 2016. Novanta Inc. was founded in 1968 and is headquartered in Bedford, Massachusetts.

Price of NOVT

NOVT FAQ

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

NOVT Earnings Table

Unit : USD

QTRNon-GAAP EPSEPS YoYEPS Surprise %SalesSales YoYSales Surprise %NPM
Current
2025Q4
2025Q3
2025Q2
2025Q1
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.50
PE Ratio (TTM)
91.45
Forward PE
-
PS Ratio (TTM)
4.93
PB Ratio
6.00
Price-to-FCF
91.90
METRIC
VALUE
vs. INDUSTRY
Gross Margin
44.39%
Net Margin
5.49%
Revenue Growth (YoY)
3.30%
Profit Growth (YoY)
3.26%
3-Year Revenue Growth
5.76%
3-Year Profit Growth
6.21%
METRIC
VALUE
vs. INDUSTRY
EPS (TTM)
1.50
PE Ratio (TTM)
91.45
Forward PE
-
PS Ratio (TTM)
4.93
PB Ratio
6.00
Price-to-FCF
91.90
Gross Margin
44.39%
Net Margin
5.49%
Revenue Growth (YoY)
3.30%
Profit Growth (YoY)
3.26%
3-Year Revenue Growth
5.76%
3-Year Profit Growth
6.21%

  • When is NOVT's latest earnings report released?

    The most recent financial report for Novanta inc. (NOVT) covers the period of 2025Q4 and was published on 2025/12/31. This report is prepared according to IFRS/US GAAP standards and includes key financial indicators—Revenue, Profitability, Cash Flow, and Capital Structure. This information is essential for investors evaluating NOVT's short-term business performance and financial health. For the latest updates on NOVT's earnings releases, visit this page regularly.

  • Where does NOVT fall in the P/E River chart?

    According to historical valuation range analysis, Novanta inc. (NOVT)'s current price-to-earnings (P/E) ratio is 94.39, placing it in the Reasonable zone on the P/E River chart. This level indicates that the market's expectations for future earnings are already reflected in the share price, with the valuation currently leaning conservative. Investors are advised to further examine the company's fundamentals and its position in the industry cycle to validate whether the valuation is justified.

  • What is the operating profit of NOVT?

    According to the latest financial report, Novanta inc. (NOVT) reported an Operating Profit of 24.83M with an Operating Margin of 9.61% this period, representing a decline of 7.02% compared to the same period last year. Operating Profit reflects the company's core business efficiency and cost control, making it a key indicator for evaluating operational strength and profitability.

  • How is NOVT's revenue growth?

    In the latest financial report, Novanta inc. (NOVT) announced revenue of 258.35M, with a Year-Over-Year growth rate of 8.52%. Revenue growth can be driven by product mix changes, market share expansion, price adjustments, or international market penetration. Investors should also monitor gross margin and regional revenue distribution for a comprehensive view of growth quality and sustainability.

  • How much debt does NOVT have?

    As of the end of the reporting period, Novanta inc. (NOVT) had total debt of 299.56M, with a debt ratio of 0.17. Long-term debt comprises a higher/lower proportion. The level of financial leverage directly impacts the company's capital structure and interest coverage. If debt is high, pay attention to interest expenses and refinancing risks. Conversely, a low-leverage structure indicates greater risk tolerance but potentially less growth flexibility.

  • How much cash does NOVT have?

    At the end of the period, Novanta inc. (NOVT) held Total Cash and Cash Equivalents of 380.87M, accounting for 0.21 of total assets. Both current and quick ratios indicate robust short-term debt repayment ability. High cash reserves typically mean the company has strong liquidity, supporting operational needs, expansion investments, or shareholder returns.

  • Does NOVT go with three margins increasing?

    In the latest report, Novanta inc. (NOVT) achieved the “three margins increasing” benchmark, with a gross margin of 43.8%%, operating margin of 9.61%%, and net margin of 6.8%%. This demonstrates improvement in profitability, which is a key signal for fundamental analysis. Investors should consider margin trends alongside other financial indicators to assess NOVT's profit trajectory and future growth potential.

  • Is NOVT's EPS continuing to grow?

    According to the past four quarterly reports, Novanta inc. (NOVT)'s earnings per share (EPS) shows a steady growth trend, with the latest EPS at 0.46. If EPS continues to rise due to revenue growth and cost optimization, it can support P/E valuation recovery and attract long-term investors.

  • What is the FCF of NOVT?

    Novanta inc. (NOVT)'s Free Cash Flow (FCF) for the period is 5.19M, calculated as Operating Cash Flow minus Capital Expenditures, representing a fall of 91.27% compared with the previous period. Positive FCF growth provides stable funding for dividends, debt repayment, or strategic acquisitions, and is an important measure of true profitability and shareholder return potential.

  • What are the PEG ratio and PE ratio of NOVT?

    The latest valuation data shows Novanta inc. (NOVT) has a Price-To-Earnings (PE) ratio of 94.39 and a Price/Earnings-To-Growth (PEG) ratio of 1.22. A PEG below 1 usually suggests the market is underestimating growth potential, while a PEG above 1 indicates high growth expectations are already priced in. Investors should conduct a comprehensive valuation by considering historical growth, market forecasts, and industry cycles.